POSLUMA EVO
LIVE

Serial Number

50111396

Owner

Blue Earth Diagnostics Limited

Attorney

KEVIN ANDREW THOMPSON

Filing Date

Sep 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

POSLUMA EVO Trademark

Serial Number: 50111396

POSLUMA EVO is a trademark filed by Blue Earth Diagnostics Limited on September 16, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Blue Earth Diagnostics Limited (9 trademarks)

Magdalen Centre,

Entity Type: 99

Trademark Details

Filing Date

September 16, 2026

Registration Date

Not Registered

Goods & Services

Chemical preparations for use in scientific research; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracing chemicals for scientific and laboratory use; synthetic proteins and amino acids for use in Positron Emission Tomography (PET) imaging for laboratory and research use; reagents for use in Positron Emission Tomography (PET) imaging for laboratory and research use; diagnostic scanning agents for in-vivo use for medical research use; diagnostic scanning agents for in-vivo use for scientific or research use; chemicals for use in molecular imaging for scientific or research use

Diagnostic preparations for medical purposes; medical preparations in the nature of contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use in medical imaging; Positron Emission Tomography (PET) tracing chemicals for medical use; PET tracing chemicals and reagents prepared for ingestion or injection into humans and animals for medical use; diagnostic chemicals for medical purposes; reagents for medical purposes; diagnostic scanning agents for medical use; preparations for use in medical imaging, namely, contrast agents, molecular imaging agents, radiopharmaceuticals, PET agents, radiotracers, PET tracers and diagnostic imaging agents for use with imaging medical equipment; contrast agents for use in medical imaging and molecular imaging; amino acids for use in medical imaging

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 16, 2026 MAFR
NEW APPLICATION ENTERED
Sep 16, 2026 NWAP